Managers
Kidderminster-based skin care supplier Essentially Yours has secured GBP200,000 from the Midlands Engine Investment Fund (MEIF) West Midlands Debt Finance, managed by Maven Capital Partners (Maven), backed by the Coronavirus Business Interruption Scheme Loan (CBILS).
The firm plans to use the funding to accelerate product development and expand its marketing division, both of which form part of its ambitious growth plans which should create 11 new roles.
With its main operations in Kidderminster, Worcestershire – Essentially Yours has 20 years experience in developing research led botanical skin care products The business supplies various outlets, including beauty salons, hair salons and
Foresight Group (Foresight), a listed infrastructure and private equity manager group, has held the final close of Foresight Energy Infrastructure Partners (FEIP), a sustainability-led energy transition infrastructure fund investing predominantly in Europe.
FEIP has secured total commitments of EUR851.4 million, 70 per cent over the EUR500 million original target. The fund welcomed attracted additional commitments of EUR64 million from existing limited partners and an Italian institutional investor at final close.
Including co-investments to date of EUR170 million, this represents a total capital pool in excess of EUR1 billion for Foresight’s energy transition strategy. Commitments were made by over 35 leading
Flexpoint Ford, a private equity investment firm specialising in the financial services and healthcare industries, has held the final closing of its second asset investment fund, Flexpoint Asset Opportunity Fund II, (Asset Fund II), at USD825 million.
Asset Fund II will build on the strategy established in the predecessor fund, Flexpoint Special Assets Fund, LP (Asset Fund I), leveraging the firm’s focus and expertise in financial services private equity to invest in opportunistic asset-driven investments across financial services sub-sectors and assets. Asset Fund II will seek to construct a portfolio of diversified financial assets and structured investments.
“We are
EMV Capital (EMVC) invested in Cambridge-based proposed deeptech early-stage investor Martlet Capital, alongside private office Saranac Partners and other investors.
The investment enables Martlet Capital to complete the acquisition of a portfolio of 50-plus minority positions from Marshall Group, including companies in life science, healthcare, cleantech sustainability, industrial and semi-conductor technology. The total targeted investment for Martlet is at GBP22 million, providing Martlet Capital with significant firepower for further follow on and new investment opportunities.
EMV Capital is making a GBP1 million investment into Martlet Capital, and through its ‘capital light’ approach intends to syndicate a part of its initial
Delegate Connect, an end-to-end event platform, has raised AUD10 million in seed capital in its first ever funding round.
The round is one of Australia’s largest Seed rounds, and for AirTree Ventures, who led the round, it’s the biggest Seed cheque written in the fund’s history. The round also includes investment from Skip Capital, the private fund of Kim Jackson and Scott Farquhar (co-founder of Atlassian), along with investment fund TEN13. Founders of some of Australia’s top startups, including Alex Zaccaria, CEO and Founder of LinkTree, and Andrew Barnes, CEO and Founder of Go1, have also joined the oversubscribed funding
Compusoft Group, a global visual CPQ provider, has acquired Access Information Technologies (Access IT), publishers of contractERP — an ERP solution tailored to the window & door and adjacent industries.
The acquisition strengthens Compusoft’s offering to customers in the window & door industry by adding new capability to manage complex business, operational and manufacturing processes. Combined with the existing range of configuration and pricing software, Compusoft will provide an expansive solution for customers to grow and optimise their business from front-end estimation through to back-end financials.
In addition to a wider product offering, the acquisition continues to expand Compusoft’s
Commonfund Capital has held the closing of its third global private equity fund, Commonfund Capital Global Private Equity Partners III at USD236.6 million, above its prior global fund that closed at USD228.8 million.
The fund had strong participation from existing limited partners as well as a number of new investors; limited partners included pensions, foundations, endowments, insurance companies, family offices and sophisticated clients of registered investment advisors and consultants.
Commonfund Capital has been investing in private equity since 1988 and specialises in smaller and medium sized funds and managers that are sector and geographic specialists, many of which are
CGE Partners (CGE) has invested in ethiXbase, a provider of third-party risk assessment services to corporates, focusing on anti-corruption, human rights, labour, and the environment.
CGE is partnering with Leas Bachatene (CEO), Russell Potter (CFO) and Michelle Knight (Head of Operations) to back the company in its next phase of growth to become the leading global provider of supply chain risk assessment software solutions. CGE will bring significant experience and resource to support ethiXbase’s international expansion, future M&A and new product development initiatives.
Leas Bachatene, CEO of ethiXbase, comments: “ethiXbase’s mission to support organisations worldwide to adopt sustainable and socially
AUA Private Equity Partners portfolio company Westminster Pet Products, has acquired substantially all of the assets of Pet Ventures, dba Pet ‘n Shape.
Established in 2005 by the Abramson Family, Pet ‘n Shape is an emerging brand of pet treats and chews that offers a full-line of branded, high-quality products made from natural ingredients.
Joe Flanigan, CEO of Westminster, says: “The combination of Westminster and Pet ‘n Shape allows us to build on the success Pet ‘n Shape has established in the online and e-commerce channels, and enables us to serve a larger customer base, across new channels, with a
Biotech company Anjarium Biosciences (Anjarium) has closed a CHF55.5 million (USD61 million) Series A financing, co-led by Abingworth and Gimv, with significant participation from Omega Funds, Pfizer Ventures and Surveyor Capital (a Citadel company).
Anjarium’s innovative approach leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology and nanoparticle engineering to rationally design and produce tissue-targeted gene therapies, optimised to improve patient outcomes in a range of serious genetic diseases.
The Company’s unique platform combines proprietary DNA-based gene vectors, natural and synthetic nanoparticle delivery modalities – including its novel Hybridosome technology – and cost-efficient, scalable manufacturing solutions.
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
